Clinical Trial: A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07808073) titled 'A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy' on Sept. 03.

Brief Summary: The main purpose of this study is to assess how well LY4329090 is tolerated and what side effects may occur in healthy participants with obesity or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Study participants will be in one of 2 parts. For each participant in Part A, the study will last about 10 weeks and will include a stay in the Clinical Research Unit (CRU) lasting 5 nights along with 5 outpatient visits to the CRU. For ...